Lifecare ASA

Board/Management Information • Jan 23, 2024

Stock Exchange Notification Lifecare Appointment of CFO

Stock Exchange Notification Lifecare Appointment of CFO

Bergen, Norway, 23 January 2024: Lifecare AS (LIFE), a clinical stage medical

sensor company developing the next generation Continuous Glucose Monitor

(CGM), has appointed Renete Kaarvik as Chief Financial Officer effective 1

Mai, 2024.

Kaarvik joins Lifecare from the position as Global Finance Officer at Grieg

Seafood ASA, a position she has held for close to six years.

Lifecares main operational focus is to establish automated manufacturing by

end of Q2 2024, including preparations for market launch in the veterinary

market. As part of the company's growth strategy, the Board of Directors wish

to strengthen the company's executive management with focus on financial

management and strategy. In addition to the expectation of increased

commercial activities that will bring the company into a new phase, the Board

of Directors wish to explore the potential of uplisting Lifecare to Oslo Børs

Main Market.

"We are very pleased to welcome Renete to Lifecare. She brings valuable

competence and experience to the Lifecare Group. During the last year we have

repeatedly highlighted the importance of establishing solid product and

manufacturing fundaments, based on proven research and systemic quality

management. With this appointment we establish the CFO position to further

strengthen the Group capacities. We are confident that Renete will play an

important role on forming the Groups financial strategies aligned with our

growth strategy and strengthen the fundament for both the product and Group

organization to the best of the shareholders' interests", says Lifecare CEO

Joacim Holter.

Kaarvik graduated in 2004 from Macquarie University, Sydney, Australia, with a

Master of Applied Finance. She also holds a Master of Science in Business from

Bodø Graduate School of Business (1998).

In addition to the aforementioned professional experience, Kaarvik has held

Group Controller, Compliance Officer and Finance Manager positions in Mowi ASA

and Marine Farms ASA, as well as Manager and Senior Associate positions in

Ernst & Young and PricewaterhouseCoopers within Transaction and Business

Advisory Services and Auditing. Furthermore, Kaarvik's professional experience

also include Senior Associate, Project Manager and Associate positions within

private equity at HitecVision Private Equity and Arthur Andersen (Portugal).

About us

Lifecare AS is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market. Lifecare enables osmotic pressure as sensing principle, combined

with the ability to manipulate Nano-granular Tunnelling Resistive sensors

("NTR") on the sensor body for read-out of pressure variations. Lifecare's

sensor technology is referred to as "Sencell" and is suitable for identifying

and monitoring the occurrence of a wide range of analytes and molecules in the

human body.

Contacts

For further information, please contact:

Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs,

asle.wingsternes@lifecare.no, +47 41 61 42 52

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR Article 19 no. 3. The information was submitted for publication

at 2024-01-23 08:00 CET.